$MRVL

MURPHY MATTHEW J sold $2.2M of MRVL

MURPHY MATTHEW J (Chairman of the Board and CEO) sold 7,500 shares of Marvell Technology, Inc. (MRVL) at $298.76 ($2.24M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MURPHY MATTHEW J
Published Jun 16, 2026, 6:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 7:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRVL
Neutral
high confidence
Mentioned
$MRVL
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The disclosure provides a concrete insider selling datapoint (size, price, and post-transaction holdings) but does not introduce new company fundamentals; the 10b5-1 designation reduces interpretive weight.

02

Market read

Traders may monitor MRVL for any follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

The article lacks context on total insider holdings over time, whether this sale is part of a larger scheduled series, and whether there were concurrent buys by other insiders/institutions.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-16; transaction dated 2026-06-15.

Background

This is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc. (MRVL).

Company-level read

Ticker impact

$MRVLNeutralHigh confidence
Context

Marvell CEO/Chairman Matthew J. Murphy sold 7,500 shares in an open-market transaction at $298.76 on 2026-06-15 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless accompanied by other news.

Evidence & confidence

The filing is a Form 4 insider sale with an explicitly pre-arranged 10b5-1 plan, and the article provides no new operational/regulatory/financial catalyst beyond the transaction details.

Market effects

Minimal; single-company insider sale does not change sector fundamentals.

Minimal; US-listed semiconductor name with no broader macro/regional linkage in the text.

Minimal; no international deal/regulatory developments mentioned.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with valuation or liquidity needs; traders may still fade short-term rallies if selling cadence is notable.

Key entities

  • Marvell Technology, Inc.

    US-listed semiconductor company subject of the Form 4 insider sale disclosure.

  • Matthew J. Murphy

    Chairman of the Board and CEO who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.